Financial Data and Key Metrics Changes - Fourth quarter revenue was 735million,exceedingguidanceby30 million, with adjusted EBITDA of 75millionalsoaboveexpectations[7][39]−Consolidatedrevenuedecreasedby10188 million, primarily due to a non-cash goodwill impairment charge of 222million[40][41]−Full−year2024revenuewas3 billion, a decrease of 21% year-over-year, with adjusted EBITDA down 41% to 341million[43][44]BusinessLineDataandKeyMetricsChanges−NurseandAlliedSolutionsrevenuewas455 million, down 15% year-over-year but up 14% sequentially, with average bill rates down 6% year-over-year [30][32] - Physician and Leadership Solutions revenue was 173million,up3107 million, down 5% year-over-year, with language services revenue increasing by 12% [37][38] Market Data and Key Metrics Changes - Travel nurse orders remain 20% below pre-pandemic levels, but are above April 2024 levels [9] - Allied orders grew 7% year-over-year in the fourth quarter, with new orders up 20% year-over-year [10] - Wage inflation in healthcare moved back up to 5% in Q4 2024, impacting staffing gross margins [13] Company Strategy and Development Direction - The company is focused on innovation and service to healthcare professionals, with a mission to provide integrated technology solutions [16][21] - The launch of next-generation technology solutions like ShiftWise Flex and Passport aims to enhance operational efficiency and client engagement [18][20] - The company is positioned to capture share in a 41billionaddressablemarketbyexpandingserviceofferingsandimprovingclient−centricstrategies[21][23]Management′sCommentsonOperatingEnvironmentandFutureOutlook−Managementnotedsignsofstabilizationintheindustry,withexpectationsforpatientvolumegrowthof375 million in revolver debt during the fourth quarter, reflecting strong cash flow [8] - Days sales outstanding improved to 55 days, 15 days lower than a year ago [42] - The company appointed Mark Foletta as the new Board Chairman following Doug Wheat's retirement [47] Q&A Session Summary Question: What are the expectations for gross margins in Nurse and Allied? - Management indicated that gross margins in Q1 are expected to be similar to Q4, with stable trends anticipated [54] Question: How does the company view the normalization of demand? - Management noted a return to normalcy in demand patterns, with expectations for increased patient demand and wage inflation impacting orders [62][64] Question: What is the outlook for international revenue? - The company expects a 100millionrevenueheadwindbetween2024and2025,primarilyinthefirsthalfof2025[73]Question:Howisthecompetitivelandscapeevolving?−Managementobservedstrongcompetitionbutnotedarationalapproachfromcompetitorsregardingpricingandcapacity[116][123]Question:WhataretheexpectationsforVMSrevenueinQ1?−VMSrevenueisexpectedtobeslightlyunder20 million in Q1, with stabilization anticipated as new client wins are implemented [106][108]